Literature DB >> 11053710

Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy.

M V Simões1, A O Pintya, G Bromberg-Marin, A V Sarabanda, C M Antloga, A Pazin-Filho, B C Maciel, J A Marin-Neto.   

Abstract

Impairment of sinus node autonomic control and myocardial perfusion disturbances have been described in patients with chronic Chagas' cardiomyopathy. However, it is not clear how these conditions contribute to myocardial damage. In this investigation, iodine-123 (I-123) meta-iodobenzylguanidine (MIBG) and thallium-201 myocardium segmental uptake were studied in correlation with the severity of left ventricular (LV) dysfunction detected in various phases of Chagas' heart disease. Group I consisted of 12 subjects (43 +/- 4 years, 7 men) with no symptoms and no cardiac involvement on electrocardiogram (ECG) or echocardiography; group II consisted of 13 patients (48 +/- 3 years, 9 men) with abnormal resting ECG and/or echocardiographic segmental abnormalities, and LV ejection fraction of > or = 0.5; group III was comprised of 12 patients (59 +/- 3 years, 10 men) with more severe heart disease, LV dilation, and LV ejection fraction of < 0.5. Eighteen control volunteers (38 +/- 3 years, 9 men) were also included in the study. I-123 MIBG single-photon emission computed tomographic (SPECT) segmental uptake defects were observed in group I (33%), group II (77%), and group III (92%). Quantitative analysis showed mean areas of reduced LV I-123-MIBG uptake: group I was 3.7 +/- 2.1%; group II was 8.3 +/- 2.3%; and group III was 19.0 +/- 3.3%. The differences between group I and both groups II and III were statistically significant (p < 0.001, analysis of variance test). Myocardial perfusion defects (reversible, fixed, and paradox) were observed in group I (83%), group II (69%), and group III (83%). A marked topographic association between perfusion, innervation, and wall motion abnormalities (assessed by gated-SPECT perfusion studies) was observed in all the groups. Defects predominated in the inferior, posterior lateral, and apical LV regions. Thus, extensive impairment of cardiac sympathetic function at the ventricular level occured early in the course of Chagas' cardiomyopathy and was related to regional myocardial perfusion disturbances, before wall motion abnormalities. Both conditions are associated with progression of ventricular dysfunction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053710     DOI: 10.1016/s0002-9149(00)01133-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  25 in total

1.  Abnormalities in fractal heart rate dynamics in Chagas disease.

Authors:  Marcos Roberto de Sousa; Heikki V Huikuri; Federico Lombardi; Amanda A Perez; Murilo E D Gomes; Marcio Vinícius Lins Barros; Vladimir Costa Val Barros; Manoel Otávio Costa Rocha; Antonio Luiz Pinho Ribeiro
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-04       Impact factor: 1.468

Review 2.  Chagas heart disease: report on recent developments.

Authors:  Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

Review 3.  Role of autoantibodies in the physiopathology of Chagas' disease.

Authors:  Emiliano Horacio Medei; José Hamilton Matheus Nascimento; Roberto Coury Pedrosa; Antônio Carlos Campos de Carvalho
Journal:  Arq Bras Cardiol       Date:  2008-10       Impact factor: 2.000

Review 4.  The vasculature in chagas disease.

Authors:  Cibele M Prado; Linda A Jelicks; Louis M Weiss; Stephen M Factor; Herbert B Tanowitz; Marcos A Rossi
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

5.  Ventricular arrhythmias in chronic Chagas cardiomyopathy: Can studying myocardial sympathetic denervation provide the answers?

Authors:  Vineet Kumar
Journal:  J Nucl Cardiol       Date:  2016-07-12       Impact factor: 5.952

6.  The long way to defeating Chagas cardiomyopathy.

Authors:  Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2018-02-21       Impact factor: 5.952

7.  Dyskinesis in Chagasic myocardium: centerline analysis of wall motion using cardiac-gated magnetic resonance images of mice.

Authors:  Jorge L Durand; Baiyu Tang; David E Gutstein; Stefka Petkova; Mauro M Teixeira; Herbert B Tanowitz; Linda A Jelicks
Journal:  Magn Reson Imaging       Date:  2006-05-26       Impact factor: 2.546

8.  Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy.

Authors:  Denise Mayumi Tanaka; Luciano Fonseca Lemos de Oliveira; José Antônio Marin-Neto; Minna Moreira Dias Romano; Eduardo Elias Vieira de Carvalho; Antonio Carlos Leite de Barros Filho; Fernando Fonseca França Ribeiro; Jorge Mejia Cabeza; Carla Duque Lopes; Camila Godoy Fabricio; Norival Kesper; Henrique Turin Moreira; Lauro Wichert-Ana; André Schmidt; Maria de Lourdes Higuchi; Edécio Cunha-Neto; Marcus Vinícius Simões
Journal:  J Nucl Cardiol       Date:  2018-02-01       Impact factor: 5.952

Review 9.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

Review 10.  Coronary microvascular disease in chronic Chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms.

Authors:  Marcos A Rossi; Herbert B Tanowitz; Lygia M Malvestio; Mara R Celes; Erica C Campos; Valdecir Blefari; Cibele M Prado
Journal:  PLoS Negl Trop Dis       Date:  2010-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.